Cardiol Therapeutics Inc. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Biological Products, (No Diagnostic Substances).
No upcoming catalysts are currently on record for CRDL. Past events are listed below.
Cash runway is approximately 10.8 months based on the most recent reported cash position and quarterly operating burn as of 2025-12-31.
Upcoming catalysts
Nothing scheduled.
Track CRDL alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.